Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety

@article{Lattanzi2019ErenumabFP,
  title={Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety},
  author={S. Lattanzi and Francesco Brigo and E. Trinka and F. Vernieri and Tommaso Corradetti and M. Dobran and M. Silvestrini},
  journal={Drugs},
  year={2019},
  volume={79},
  pages={417-431}
}
  • S. Lattanzi, Francesco Brigo, +4 authors M. Silvestrini
  • Published 2019
  • Medicine
  • Drugs
  • BackgroundNovel therapeutic options with improved efficacy and safety profiles are needed for the prophylaxis of migraine. In recent years, the inhibition of calcitonin gene-related peptide (CGRP) signaling has attracted growing interest in the pharmacological research on migraine. Erenumab is the first fully human monoclonal antibody directed against the CGRP receptor to be approved for use in migraineurs.ObjectiveTo evaluate the efficacy and safety of erenumab as preventive treatment in… CONTINUE READING
    24 Citations
    The role of erenumab in the treatment of migraine
    • 2
    Recent Advances in Pharmacotherapy for Episodic Migraine
    • 8
    Erenumab in the treatment of migraine.
    • 6
    • PDF

    References

    SHOWING 1-10 OF 57 REFERENCES
    Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
    • 260
    • Highly Influential
    • PDF
    ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
    • 160
    • Highly Influential
    • PDF
    Early onset of efficacy with erenumab in patients with episodic and chronic migraine
    • 26
    A Controlled Trial of Erenumab for Episodic Migraine
    • 317
    • Highly Influential
    Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
    • 192
    • Highly Influential
    Erenumab in the treatment of migraine.
    • 6
    • PDF
    Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
    • 24
    Drug safety and tolerability in prophylactic migraine treatment
    • 28
    • PDF